aspirin and cangrelor

aspirin has been researched along with cangrelor in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	21 (45.65)	29.6817
2010's	18 (39.13)	24.3611
2020's	7 (15.22)	2.80

Authors

Authors	Studies
Cameron, KE; Heptinstall, S; May, JA; Sanderson, HM; Storey, RF; White, AE	1
Oldroyd, KG; Storey, RF; Wilcox, RG	1
Bath, P; Heptinstall, S; Zhao, L	1
Heptinstall, S; Judge, HM; Storey, RF; Wilcox, RG	1
Bath, PM; Fox, S; Heptinstall, S; Judge, H; Lösche, W; May, J; Zhao, L	1
Grieco, G; Jonas, S	1
Graff, J; Harder, S; Klinkhardt, U	1
Heptinstall, S; May, JA; Storey, RF	1
Fälker, K; Lange, D; Presek, P	1
Graff, J; Harder, S	1
Buckland, RJ; Holgate, CE; Judge, HM; Storey, RF	1
Gurbel, PA; Tantry, US	1
Brandl, R; Deckmyn, H; Penz, SM; Reininger, AJ; Siess, W; Toth, O	1
Fox, SC; Heptinstall, S; White, AE; Wilcox, RG; Xavier, RG	1
Barker, CM; Price, MJ	1
Angiolillo, DJ; Guzman, LA	1
Eikelboom, JW; Hirsh, J; Raju, NC	1
Béres, BJ; Kerecsen, G; Kiss, RG; László, A; Masszi, T; Préda, I; Tóth-Zsámboki, E; Vargová, K	1
Dovlatova, N; Espinosa, DI; Fox, SC; Glenn, JR; Gurney, M; Hartman, D; Heptinstall, S; Hermann, D; Johnson, A; Magnusson, O; Manolopoulos, P; May, JA; Stefansson, K; White, AE	1
Butt, M; Lip, GY; Shantsila, E; Siddique, A	1
Fox, SC; Heptinstall, S; May, JA; Neubert, U; Shah, A	1
Frey, N; Ivandic, B	1
Ağırbaşlı, M; Cinçin, A; Güvenç, H	1
Dovlatova, N; Fox, SC; Glenn, JR; Heptinstall, S; Iyú, D; White, AE	1
Moliterno, DJ; Rajan, L	1
Caglayan, E; Er, F; Erdmann, E; Gassanov, N	1
Contractor, H; Ruparelia, N	1
Dibattiste, PM; Ringwala, SM; Schneider, DJ	1
Lavi, R; Lavi, S	1
Angiolillo, DJ; Cho, JR; Franchi, F; Muñiz-Lozano, A; Rollini, F	1
Dobesh, PP; Oestreich, JH	1
Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L	1
Angiolillo, DJ; Franchi, F; Park, Y; Rollini, F	1
Frelinger, AL; Gremmel, T; Michelson, AD; Przyklenk, K; Undyala, VV; Wider, J; Wright, GE; Yanachkov, IB; Yanachkova, MI	1
Burris, RJ; Seto, AH; Tyler, JM	1
Calnan, MW; Crawford, AN	1
Farag, M; Gorog, DA; Gue, YX; Spinthakis, N; Srinivasan, M; Wellsted, DM	1
Aghaebrahim, A; Agnoletto, GJ; Aguilar-Salinas, P; Brasiliense, LBC; Gonsales, D; Granja, MF; Hanel, RA; Santos, R; Sauvageau, E	1
Banerjee, S; Baskar, A; Chauhan, S; Cui, Z; Dargham, BB; Sum-Ping, J; Tejani, I; Weideman, RA	1
Dagois, S; De Mesmay, M; Devys, JM; Dupont, C; Godier, A; Mazighi, M; Mesnil, M; Thion, LA	1
Abdennour, L; Bernard, R; Carpentier, A; Clarençon, F; Degos, V; Drir, M; Godier, A; Lenck, S; Mathout, J; Premat, K; Shotar, E; Sourour, N; Taylor, G	1
Bozzi, S; Cattaneo, M; Mencarini, T; Podda, G; Redaelli, A; Scavone, M	1
Finniss, M; Helton, T; Khalid, M; Khan, AA; Murtaza, G	1
Aknouche, S; Allard, J; Blanc, R; Ciccio, G; Delvoye, F; Desilles, JP; Escalard, S; Hebert, S; Labreuche, J; Maertens de Noordhout, A; Maier, B; Mazighi, M; Obadia, M; Olivot, JM; Piotin, M; Redjem, H; Sabben, C; Smajda, S; Thion, LA	1
Calleris, G; Cedrone, M; Ceraolo, E; Gontero, P; Rosboch, GL	1
Cohan, D; Konopka, CI; Montepara, CA; Uricchio, MN; Verlinden, NJ	1

Reviews

15 review(s) available for aspirin and cangrelor

Article	Year
Potential value of triple antiplatelet therapy for secondary stroke prevention. Stroke, 2003, Volume: 34, Issue:10 Topics: Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Treatment Outcome	2003
Aspirin and clopidogrel resistance: consideration and management. Journal of interventional cardiology, 2006, Volume: 19, Issue:5 Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Restenosis; Drug Resistance; Humans; Membrane Proteins; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticagrelor; Ticlopidine	2006
Clinical overview of promising nonthienopyridine antiplatelet agents. American heart journal, 2008, Volume: 156, Issue:2 Suppl Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Humans; Lactones; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Receptors, Thrombin; Ticagrelor	2008
Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future. Nature clinical practice. Cardiovascular medicine, 2008, Volume: 5, Issue:12 Topics: Adenosine; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; History, 20th Century; History, 21st Century; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2008
New antiplatelet drugs: beyond aspirin and clopidogrel. International journal of clinical practice, 2009, Volume: 63, Issue:5 Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Drug Design; Humans; Imines; Lactones; Naphthalenes; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propionates; Purinergic P2 Receptor Antagonists; Pyridines; Thiophenes; Ticagrelor; Ticlopidine	2009
[New approaches and indications for the analysis of platelet function in cardiology]. Hamostaseologie, 2011, May-02, Volume: 31, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Hemorrhage; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine	2011
[Novel agents in antiplatelet therapy]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2010, Volume: 38, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Humans; Lactones; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Thiophenes; Ticagrelor; Ticlopidine	2010
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS? Current cardiology reports, 2011, Volume: 13, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quinazolinones; Receptors, Purinergic P2Y12; Sulfonamides; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine	2011
[ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:27 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyridines; Receptors, Purinergic P2; Stents; Ticlopidine	2011
Advances in antiplatelet therapy for acute coronary syndromes. Postgraduate medical journal, 2012, Volume: 88, Issue:1041 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Emergency Treatment; Female; Humans; Male; Patient Selection; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Quinazolinones; Sulfonamides; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2012
Perioperative management of antiplatelet agents in patients undergoing cardiac surgery. Journal of cardiothoracic and vascular anesthesia, 2012, Volume: 26, Issue:4 Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Coronary Artery Bypass; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticagrelor; Ticlopidine	2012
Cangrelor: a review on pharmacology and clinical trial development. Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:10 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Animals; Aspirin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists	2013
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? American heart journal, 2014, Volume: 168, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin	2014
A Safety Evaluation of Cangrelor in Patients Undergoing PCI. Expert opinion on drug safety, 2016, Volume: 15, Issue:2 Topics: Adenosine Monophosphate; Aspirin; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists	2016
Why we need intravenous antiplatelet agents. Future cardiology, 2016, Volume: 12, Issue:5 Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Humans; Injections, Intravenous; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists	2016

Trials

2 trial(s) available for aspirin and cangrelor

Article	Year
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis and haemostasis, 2001, Volume: 85, Issue:3 Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Angina, Unstable; Aspirin; Blood Coagulation Tests; Consumer Product Safety; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12	2001
Effects on platelet function of a direct acting antagonist of coagulation factor Xa. Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:3 Topics: Adenosine Monophosphate; Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Disease; Crotalid Venoms; Factor Xa; Factor Xa Inhibitors; Female; Humans; Lectins, C-Type; Male; Middle Aged; Morpholines; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Rivaroxaban; Thiophenes	2012

Article

Year

Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.

Thrombosis and haemostasis, 2001, Volume: 85, Issue:3

Topics: Acute Disease; Adenosine Monophosphate; Adult; Aged; Angina, Unstable; Aspirin; Blood Coagulation Tests; Consumer Product Safety; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12

2001

Effects on platelet function of a direct acting antagonist of coagulation factor Xa.

Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:3

Topics: Adenosine Monophosphate; Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Artery Disease; Crotalid Venoms; Factor Xa; Factor Xa Inhibitors; Female; Humans; Lectins, C-Type; Male; Middle Aged; Morpholines; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Rivaroxaban; Thiophenes

2012

Other Studies

29 other study(ies) available for aspirin and cangrelor

Article	Year
The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. British journal of haematology, 2000, Volume: 110, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Analysis of Variance; Annexin A5; Aspirin; Blood Platelets; Calcium; Collagen; Cytosol; Fibrinolytic Agents; Flow Cytometry; Humans; Membrane Proteins; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Serotonin; Stimulation, Chemical; Thromboxane A2	2000
Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. British journal of pharmacology, 2001, Volume: 134, Issue:2 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Communication; Dipyridamole; Drug Synergism; Flow Cytometry; Humans; Leukocytes; Macrophage-1 Antigen; Monocytes; Neutrophils; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors	2001
Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thrombosis and haemostasis, 2002, Volume: 88, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Adhesion; Clopidogrel; Drug Therapy, Combination; Female; Humans; Leukocytes; Male; Membrane Proteins; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine	2002
The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current medical research and opinion, 2003, Volume: 19, Issue:3 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD11b Antigen; Dipyridamole; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Leukocytes; Monocytes; Neutrophils; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Thiazolidines; Thromboplastin	2003
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators. Thrombosis research, 2004, Volume: 113, Issue:5 Topics: Abciximab; Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; Cell Degranulation; Collagen; Drug Interactions; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Oligopeptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12	2004
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Thrombosis research, 2005, Volume: 115, Issue:4 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12	2005
P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Thrombosis and haemostasis, 2005, Volume: 93, Issue:5 Topics: Adenine; Adenosine Diphosphate; Adenosine Monophosphate; Adenylyl Cyclases; Aspirin; Blood Platelets; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Epinephrine; Epoprostenol; Humans; Membrane Proteins; Oligopeptides; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; Thrombin; Time Factors; Tyrosine	2005
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Monitoring; Eptifibatide; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sensitivity and Specificity; Ticlopidine	2005
Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses. Platelets, 2005, Volume: 16, Issue:7 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD40 Ligand; Coagulants; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Secretory Vesicles; Tirofiban; Tyrosine	2005
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thrombosis and haemostasis, 2007, Volume: 97, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Atherosclerosis; Blood Coagulation Tests; Blood Platelets; Carotid Stenosis; Dose-Response Relationship, Drug; Hemorheology; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Time Factors; von Willebrand Factor	2007
Enhanced platelet aggregation and activation under conditions of hypothermia. Thrombosis and haemostasis, 2007, Volume: 98, Issue:6 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adenosine Monophosphate; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Blood Specimen Collection; Citrates; Cold Temperature; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hirudins; Humans; Hypothermia, Induced; In Vitro Techniques; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Platelet Membrane Glycoproteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Receptors, Thrombin; Tetraspanin 30; Time Factors	2007
Antiplatelet therapy in acute coronary syndromes. Current cardiology reports, 2008, Volume: 10, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Thiophenes; Ticagrelor; Ticlopidine	2008
Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Thrombosis and haemostasis, 2008, Volume: 100, Issue:5 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adrenergic alpha-Antagonists; Aged; Aspirin; Blood Platelets; Clopidogrel; Collagen; Coronary Artery Disease; Drug Resistance; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Adrenergic, alpha-2; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Failure	2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets, 2008, Volume: 19, Issue:8 Topics: Acrylamides; Adenosine Monophosphate; Aspirin; Atherosclerosis; Blood Platelets; Cells, Cultured; Dinoprostone; Drug Interactions; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y12; Sulfones	2008
Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets, 2009, Volume: 20, Issue:4 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Drug Monitoring; Female; Flow Cytometry; Humans; Male; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Tissue Fixation	2009
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP. Platelets, 2011, Volume: 22, Issue:7 Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Adhesion Molecules; Cyclic AMP; Humans; Microfilament Proteins; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins E; Purinergic P2Y Receptor Antagonists; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Purinergic P2Y12	2011
Cangrelor for treatment during percutaneous coronary intervention. Future cardiology, 2014, Volume: 10, Issue:2 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Stents	2014
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:3 Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Animals; Aspirin; Blood Coagulation; Blood Platelets; Coronary Thrombosis; Dinucleoside Phosphates; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Time Factors; Young Adult	2016
A Case Report of Cangrelor Bridge Therapy for a Diagnostic Bronchoscopy With Biopsy. Journal of pharmacy practice, 2020, Volume: 33, Issue:2 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Aspirin; Biopsy; Bronchoscopy; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor	2020
Effect of P2Y Thrombosis research, 2019, Volume: 173 Topics: Adenosine Monophosphate; Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Fibrin Clot Lysis Time; Fibrinolysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor	2019
Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study. Journal of neurointerventional surgery, 2019, Volume: 11, Issue:4 Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Drug Therapy, Combination; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stents; Stroke; Thrombectomy; Treatment Outcome	2019
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention. Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:9 Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Tirofiban; Treatment Outcome	2019
Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series. British journal of anaesthesia, 2019, Volume: 123, Issue:1 Topics: Adenosine Monophosphate; Aspirin; Brain; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents	2019
Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms. Clinical neuroradiology, 2020, Volume: 30, Issue:3 Topics: Adenosine Monophosphate; Aneurysm, Ruptured; Aspirin; Cerebral Angiography; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Stents	2020
Platelet Adhesion and Thrombus Formation in Microchannels: The Effect of Assay-Dependent Variables. International journal of molecular sciences, 2020, Jan-23, Volume: 21, Issue:3 Topics: Adenosine Monophosphate; Aspirin; Blood Platelets; Collagen; Cyclooxygenase Inhibitors; Humans; Male; Microfluidics; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Young Adult	2020
Efficacy of Cangrelor as Bridging Therapy Post PCI. Cardiovascular & hematological disorders drug targets, 2020, Volume: 20, Issue:3 Topics: Adenosine Monophosphate; Aged; Aspirin; Colectomy; Colonic Neoplasms; Drug-Eluting Stents; Factor Xa Inhibitors; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Thrombosis; Ticagrelor	2020
Antiplatelet Therapy During Emergent Extracranial Internal Carotid Artery Stenting: Comparison of Three Intravenous Antiplatelet Perioperative Strategies. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021, Volume: 30, Issue:2 Topics: Abciximab; Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Drug Administration Schedule; Emergencies; Endovascular Procedures; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stents; Time Factors; Treatment Outcome	2021
Dual antiplatelet therapy with aspirin and cangrelor and spinal anesthesia for a urological procedure. Minerva anestesiologica, 2023, Volume: 89, Issue:4 Topics: Adenosine Monophosphate; Anesthesia, Spinal; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors	2023
Comparison of clinical outcomes with cangrelor plus aspirin versus oral dual antiplatelet therapy in patients supported with venoarterial extracorporeal membrane oxygenation. Artificial organs, 2023, Volume: 47, Issue:10 Topics: Aspirin; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Thrombosis; Treatment Outcome	2023